3.9 Provisions and contingent liabilities
Provisions are recognised when the Company has a
present legal or constructive obligation as a result
of past events, it is probable that an outflow of
resources will be required to settle the obligation
and the amount can be reliably estimated. Provisions
are not recognised for future operating losses.
Provisions are measured at the present value of
management's best estimate of the expenditure
required to settle the present obligation at the end
of the reporting period. The discount rate used to
determine the present value is a pre-tax rate that
reflects current market assessments of the time
value of money and the risks specific to the liability.
The increase in the provision due to the passage of
time is recognised as interest expense.
A contract is considered onerous when the expected
economic benefits to be derived by the Company
from the contract are lower than the unavoidable
cost of meeting its obligation under the contract.
The provision for an onerous contract is measured
at the lower of expected cost of terminating the
contract and the expected net cost of continuing
with the contract. Before a provision is established,
the Company recognises any impairment loss on
the assets associated with that contract.
A contingent liability is a possible obligation that
arises from a past event, with the resolution of
the contingency dependent on uncertain future
events, or a present obligation where no outflow
is probable. Material contingent liabilities are
disclosed in the standalone financial statements
unless the possibility of an outflow of economic
resources is remote.
3.10 Revenue recognition
Revenue from contracts with customers
The Company earns revenue from rendering
business process management services to
related parties.
Revenue is recognised upon transfer of control
of promised products or services in an amount
that reflects the transaction price (net of
variable consideration) allocated to a particular
performance obligation.
Nature of the services
The Company derives its Revenue from providing
comprehensive business process management
(BPM) services including tech enabled solutions
across the payers and providers in the US Healthcare
industry through its subsidiaries. The payer value
chain comprises of claims management, payment
integrity, clinical management, provider network
operations, and front-office services, among
others. The provider value chain includes end-
to-end Revenue Cycle Management, integrating
patient access, A/R management, and clinical
services with licensed professionals.
The Company has revenue share arrangement with
its subsidiaries present in United States, pursuant
to which, it recognizes an agreed share on the total
value of revenue from end client as its revenue.The
Company's contractual right to revenue is based
on the revenue from the end customer, net of all
elements of variable consideration, to the extent
accounted for by its subsidiaries.
Contract Asset and Liabilities
The Company classifies its right to consideration in
exchange for deliverables as either a receivable or
a contract asset.
A receivable is a right to consideration that
is unconditional. A right to consideration is
unconditional if only the passage of time is required
before payment of that consideration is due. For
example, the Company recognizes a receivable for
revenues related to time and materials contracts
or volume based contracts. The Company presents
such receivables as part of trade receivables at
their net estimated realizable value. The same is
tested for impairment as per the guidance in Ind AS
109 using expected credit loss method.
Others
Any change in scope or price is considered as a
contract modification. The Company accounts for
modifications to existing contracts by assessing
whether the services added are distinct and whether
the pricing is at the stand-alone selling price.
Services added that are not distinct are accounted
for on a cumulative catch up basis, while those that
are distinct are accounted for prospectively, either
as a separate contract if the additional services
are priced at the stand-alone selling price, or as
a termination of the existing contract and creation
of a new contract if not priced at the stand-alone
selling price.
The Company recognises an onerous contract
provision when it is probable that the unavoidable
costs of meeting the obligations under a contract
exceed the economic benefits to be received.
The Company accounts for variable considerations
like, volume discounts, rebates and pricing
incentives to customers as reduction of revenue
on a systematic and rational basis over the period
of the contract.
The Company estimates an amount of such variable
consideration using expected value method or the
single most likely amount in a range of possible
consideration depending on which method better
predicts the amount of consideration to which the
Company may be entitled.
Revenues are shown net of allowances/ returns,
sales tax, value added tax, goods and services tax
and applicable discounts and allowances.
Incremental costs that relate directly to a contract
and incurred in securing a contract with a customer
are recognised as an asset when the Company
expects to recover these costs and amortised over
the contract term.
The Company assesses the timing of the transfer
of goods or services to the customer as compared
to the timing of payments to determine whether
a significant financing component exists. As a
practical expedient, the Company does not assess
the existence of a significant financing component
when the difference between payment and transfer
of deliverables is a year or less. If the difference in
timing arises for reasons other than the provision of
finance to either the customer or us, no financing
component is deemed to exist.
Contract assets are recognised when there
is excess of revenue earned over billings on
contracts. Contract assets are classified as unbilled
receivables (only act of invoicing is pending) when
there is unconditional right to receive cash, and
only passage of time is required, as per contractual
terms. Unearned and deferred revenue ("contract
liability”) is recognised when there are billings
in excess of revenues. The billing schedules
agreed with customers could include periodic
performance-based payments and/or milestone-
based progress payments. Invoices are payable
within contractually agreed credit period agreed
with subsidiaries. Advances received for services
are reported as liabilities until all conditions for
revenue recognition are met.
Use of significant judgements in revenue
recognition
The Company's contracts with customers could
include promises to transfer multiple goods and
services to a customer. The Company assesses
the goods / services promised in a contract and
identifies distinct performance obligations in the
contract. Identification of distinct performance
obligation involves judgement to determine the
deliverables and the ability of the customer to
benefit independently from such deliverables.
The Company has applied the practical expedient
provided by Ind AS 115, whereby it does not adjust
the transaction price for the effects of the time
value of money where the period between when
the control on goods and services transferred to
the customer and when payment thereof is due,
is one year or less. Any consideration payable to
the customer is adjusted to the transaction price,
unless it is a payment for a distinct good or service
from the customer.
The Company uses judgement to determine
an appropriate standalone selling price for a
performance obligation. The Company allocates the
transaction price to each performance obligation
on the basis of the relative standalone selling price
of each distinct good or service promised in the
contract. Where standalone selling price is not
observable, the Company uses the expected cost-
plus margin approach to allocate the transaction
price to each distinct performance obligation.
The Company exercises judgement in determining
whether the performance obligation is satisfied at a
point in time or over a period of time. The Company
considers indicators such as how a customer
consumes benefits as services are rendered or
who controls the asset as it is being created or
existence of enforceable right to payment for
performance to date and alternate use of such good
or service, transfer of significant risks and rewards
to the customer, acceptance of delivery by the
customer, etc.
The Company disaggregates revenue from
contracts with customers by nature of services
rendered, customer category and pattern of
revenue recognition.
3.11 Earnings / (loss) per share
Basic earnings/ (loss) per share is computed by
dividing the net profit for the year attributable
to equity shareholders by the weighted average
number of equity shares outstanding during the
year. Partly paid equity shares are treated as a
fraction of an equity share to the extent that they
are entitled to participate in dividends relative to
a fully paid equity share during the reporting year.
The weighted average number of equity shares
outstanding during the year is adjusted for events
such as shares issued as consideration for common
control transactions, bonus issue, amalgamations,
bonus element in a rights issue, buyback, share
split, and reverse share split (consolidation of
shares) that have changed the number of equity
shares outstanding, without a corresponding
change in resources.
The number of equity shares used in computing
diluted earnings per share comprises the weighted
average number of equity shares considered to
derive the basic EPS, and also the weighted average
number of equity shares that could have been
issued on conversion of all the dilutive potential
equity shares which are deemed converted at the
beginning of reporting period, unless issued at a
later date.
3.12 Tax expense
Tax expense comprises current and net change in
the deferred tax asset or liability during the year.
Current tax and deferred tax are recognised in
standalone statement of profit and loss except to
the extent that it relates to a business combination,
or items recognised directly in equity or in other
comprehensive income.
The Company has determined that interest and
penalties related to income taxes do not meet the
definition of income taxes, and therefore accounted
for them as finance cost in the standalone statement
of profit and loss.
Current tax is the expected tax payable or receivable
on the taxable income or loss for the year, using
tax rates enacted or substantively enacted at the
reporting date, and any adjustment to tax payable
in respect of previous years. The amount of tax
payable or receivable is the best estimate of the
tax amount expected to be paid or received that
reflects uncertainty related to income taxes, if any.
Current tax assets and liabilities are offset only
if it has a legally enforceable right to set off the
recognized amounts and where it intends either to
settle on a net basis, or to realize the asset and
settle the liability simultaneously.
Deferred income tax assets and liabilities is
recognised using the balance sheet approach.
Deferred tax is recognized on temporary
differences at the reporting date between the tax
bases of assets and liabilities and their carrying
amounts for financial reporting purposes, except
when the deferred income tax arises from the initial
recognition of goodwill or an asset or liability in a
transaction that is not a business combination and
affects neither accounting nor taxable profit and
loss at the time of the transaction. The carrying
amount of deferred income tax assets is reviewed
at each reporting date and reduced to the extent
that it is no longer probable that sufficient taxable
profit will be available to allow all or part of the
deferred income tax asset to be utilized.
The measurement of deferred taxes reflects the
tax consequences that would follow the way
the Company expects, at the reporting date, to
recover or settle the carrying amount of its assets
and liabilities. Deferred tax is measured at the tax
rates that are expected to be applied to temporary
differences when they reverse, based on the laws
that have been enacted or substantively enacted by
the reporting date.
Deferred tax assets and liabilities are offset if there
is a legally enforceable right to offset current tax
liabilities and assets, and they relate to taxes levied
by the same tax authority on the same taxable
entity, or on different tax entities, but they intend
to settle current tax liabilities and assets on a
net basis or their tax assets and liabilities will be
realised simultaneously.
Deferred tax assets are recognised for unused tax
losses, unused tax credits and deductible temporary
differences to the extent that it is probable that
future taxable profits will be available against
which they can be used. Future taxable profits
are determined based on the reversal of relevant
taxable temporary differences. If the amount of
taxable temporary differences is insufficient to
recognise a deferred tax asset in full, then future
taxable profits, adjusted for reversals of existing
temporary differences, are considered, based on
the business plans for individual subsidiaries in the
Company. Deferred tax assets are reviewed at each
reporting date and are reduced to the extent that
it is no longer probable that the related tax benefit
will be realised; such reductions are reversed when
the probability of future taxable profits improves.
Unrecognised deferred tax assets are reassessed
at each reporting date and recognised to the extent
that it has become probable that future taxable
profits will be available against which they can
be used.
In determining the amount of current and deferred
tax, the Company takes into account the impact of
uncertain tax positions and whether additional taxes
and interest may be due. This assessment relies
on estimates and assumptions and may involve
a series of judgements about future events. New
information may become available that causes the
Company to change its judgement regarding the
adequacy of existing tax liabilities; such changes to
tax liabilities will impact tax expense in the period
that such a determination is made.
3.13 Borrowing costs
Borrowing cost includes interest, amortization
of ancillary costs incurred in connection with
the arrangement of borrowings and exchange
differences arising from foreign currency
borrowings to the extent they are regarded as an
adjustment to the interest cost.
3.14 Other income
Interest income is recognized as it accrues in the
standalone statement of profit and loss using
effective interest rate method.
3.15 Segment reporting
Operating segments are reported in a manner
consistent with the internal reporting provided to
the chief operating decision maker (CODM).
3.16 Share based payments arrangements
The Company measures compensation cost relating
to share-based payments using the fair valuation
method in accordance with Ind AS 102, Share-Based
Payments. Compensation expense is amortized
over the vesting period of the option on a graded
basis. The options generally vest in a graded manner
over the vesting period. The fair value determined
at the grant date is expensed over the vesting
period of the respective tranches of such options.
In Company share based payment arrangements,
where the Company is either the settling entity
for the share based awards or has an obligation to
make payments to the parent company who is the
sponsor of such awards, the awards are classified
as cash settled in accordance with Ind AS. The cost
of such cash-settled transactions is determined
based on the fair value at the date when the grant
is made and updated at each reporting date. The
expected term of the awards is estimated based on
the vesting term and contractual life of the award.
In Company share based payment arrangements,
where the Company is neither the settling entity
for the share based awards nor has an obligation to
make payments to the parent company who is the
sponsor of such awards, the awards are classified as
equity settled in accordance with Ind AS. The cost
of such equity-settled transactions is determined
by the fair value at the date when the grant is made
using the Black-Scholes valuation model. The
expected term of the awards is estimated based on
the vesting term and contractual life of the award.
The cost of cash settled transactions is recognised,
together with a corresponding increase in the
liability, over the period in which the performance
and/or service conditions are fulfilled. The
cumulative expense recognised for cash-settled
transactions at each reporting date until the
vesting date reflects the extent to which the
vesting period has expired and the Company's best
estimate of the number of equity instruments that
will ultimately vest. Debit or credit in standalone
statement of profit and loss for a period represents
the movement in cumulative expense recognized
as at the beginning and end of that period and is
recognized in employee benefits expense.
When the terms and conditions of a cash-settled
share-based payment transaction are modified
with the result that it becomes an equity-settled
share-based payment transaction, the transaction
is accounted for as such from the date of the
modification. Such modification has following
impact on standalone financial statements :
(a) The equity-settled share-based payment
transaction is measured by reference to the
fair value of the equity instruments granted at
the modification date. Therefore, the equity-
settled share-based payment transaction
is recognised in equity on the modification
date to the extent to which services have
been received.
(b) The liability recognized previously for the cash-
settled share-based payment transaction as
at the modification date is derecognised on
modification date.
(c) Any difference between the carrying amount
of the liability derecognised and the amount
of equity recognised on the modification date
is recognised immediately in profit or loss.
3.17 Investment in subsidiaries
Investment in equity instruments of subsidiaries are
measured at cost less impairment, if any.
Impairment test of Goodwill
Goodwill is tested for impairment at each reporting date.The recoverable amount of a CGU is the higher of its fair
value less cost of disposal and its value-in-use.The recoverable amount of the CGUs was determined based on
its value-in-use.The value-in-use is determined based on cash flow projections over a period of five years and
terminal growth rate there after. The key assumptions used in the estimation of the value-in-use are set out below.
The values assigned to revenue and EBITDA growth rates are based on management's assessment of future trends
in the relevant businesses and are also based on historical data from both internal and external sources.Terminal
growth rates (beyond 5 years) and the discount rate for goodwill impairment purposes have been estimated based
on macroeconomic conditions and business factors.
*Vide an agreement entered into on 31st May 2024, out of the outstanding promissory notes in the books of
of Sagility (US) Inc. an amount of USD 89.29 Million ('7,444.95 Million) was converted into equity. As part of
this transaction, the Company's wholly owned subsidiary, Sagility (US) Holdings Inc. issued 32,906.02 shares to
Sagility B.V. as consideration for conversion of the outstanding debt into equity. Contemporaneously, SIL issued
262,976,580 shares to Sagility B.V. as consideration to acquire the shares issued by Sagility (US) Holding Inc. as
consideration for the conversion of debt into equity.
The Company's wholly owned subsidiary - Sagility US Holdings Inc. had a deferred consideration liability amounting
to USD 45 Million ('3,751.94 Million) payable to the sellers in relation to the acquisitions carried out in 2022. The
liability was due to be settled on the earlier of conclusion and settlement of an ongoing dispute or obtaining a
bank guarantee from the sellers. On 22nd March 2024, Sagility B.V. received an unconditional bank guarantee
from Barclays Bank Plc on behalf of the sellers. Such bank guarantee is valid until 31st October 2026. On 31st
May 2024, Sagility (US) Holdings Inc. raised an amount of USD 44.48 Million ('3,707.73 Million) against issue of
shares to Sagility B.V. 16,393.83 shares were issued at a per share value of USD 2,713.47 ('226,166.44 per share).
Such funds received were utilized by Sagility US Holdings Inc. to settle the deferred consideration due as above.
Contemporaneously, SIL issued 131,015,338 shares to Sagility B.V. as consideration to acquire the shares issued
by Sagility (US) Holding Inc in this regard.
Pursuant to the above, the fair value of shares issued amounted to '11,150.63, at a valuation of '28.3 per share. Of
these, the face value of the shares issued amounting to '3,939.92 was recorded as equity share capital and the
differential, amounting to '7,210.72 was recorded in securities premium.
A On 26th March 2024 and 28th March 2024, SIL entered into a Share Purchase Agreement ('SPA') with Sagility B.V.,
(SIL's immediate holding company), to acquire 100% of the equity shares of Sagility P.H. B.V. (including its branch in
Philippines) and Sagility (US) Holdings Inc. (along with its downstream subsidiaries) for a purchase consideration
of USD 175.04 Million ('14,590.24 Million) and USD 628.5 Million ('52,388.86 Million) respectively. The purchase
consideration for the acquisitions was discharged by issuing 2,366,610,429 shares of SIL, valued at '28.3 per share.
The face value of the shares issued amounting to '23,666.1 Million was recorded as equity share capital and the
differential, amounting to '43,312.99 Million was recorded in securities premium.
In order to discharge the agreed purchase consideration, SIL increased the authorised share capital from '19,303.98
Million to '100,000 Million during the year ended 31st March 2024.
A1 share was held by Sagility Philippines B.V. as nominee on behalf of Sagility B.V.
*1 equity share of face value of ? 10 each are held by Siby Joy, Anand Natampalli, Sivarama Rambhatla, Krithika Srivats, Srikanth
Laksminarayan, and Benedict Richard as the registered holders on behalf of Sagility B.V., who is the beneficial owner of these
Equity Shares.
d) Terms/ rights attached to equity shares:
The Company has only one class of equity shares having a par value of '10 per share. Each holder of equity
shares, as reflected in the records of the Company as of the date of the shareholders meeting, is entitled to
one vote in respect of each share held for all matters submitted to vote in the shareholders meeting. The equity
shares are entitled to receive dividend as declared from time to time subject to approval of the shareholders
at the ensuing Annual General Meeting.
In the event of liquidation of the Company, the holders of equity shares will be entitled to receive remaining
assets of the Group after distribution of all preferential amounts, if any. The distribution will be in the proportion
to the number of equity shares held by the shareholders.
e) Aggregate number of shares issued for consideration other than cash:
The Company has not made any buy-back, nor there has been an issue of shares by way of bonus shares
during the period from incorporation up to 31st March 2025. As explained above 2,760,602,347 shares of '10
each along with a premium of '18.3 each were issued for consideration other than cash.
Sr.No Nature & purpose of reserves
(i) Effective portion of cashflow hedge
Cumulative changes in the fair value of financial instruments designated and effective as a hedge are
recognized in this reserve through OCI (net of taxes). Amounts recognized in the Effective portion of
cashflow hedge are reclassified to the standalone statement of profit and loss when the underlying
transaction occurs.
(ii) Securities premium
Securities premium is used to record the premium on issue of shares. The reserve is utilised in accordance
with the provisions of Section 52 of the Companies Act, 2013.
(iii) Retained earnings
Retained earnings comprises of prior and current year undistributed earnings / (losses) after tax.
Share based payments reserve is used to record the fair value of equity-settled share-based payment
transactions. This represents a restricted reserve and is not available for dividend distributions.
(iv) Share based payments reserve
Share based payments reserve is used to record the fair value of equity-settled share-based payment
transactions. This represents a restricted reserve and is not available for dividend distributions.
Pursuant to the facilities agreements entered into between, among others, Sagility B.V. (the immediate holding
company and formerly known as Betaine B.V.) the financial institutions listed therein as lenders dated 14th September
2021, certain assets of the Company including all of the assets of Sagility B.V. (but excluding, among other things,
shares in SIL and any other assets of Sagility B.V. located in India) were offered as security.
In connection with the second amendment and restatement agreement and pursuant to a global deed of release
entered into between, among others, Sagility B.V and The Hongkong and Shanghai Banking Corporation Limited
as security agent dated 22nd March 2024 (which took effect on 22nd March 2024) certain assets / investments
offered as security by the Company were released. Accordingly, with effect from 22nd March 2024, securities over
the Company's assets originally granted pursuant to the facilities agreement in respect of SIL and/or its subsidiaries
are no longer existing.
Note:
A. (i) On 4th January 2022, the Company allotted 13,000 Non-convertible bonds (""NCB"") at a face value of
'10,00,000 each to Sagility B.V. ( the immediate holding company)
(ii) The term of the NCB is 60 (Sixty) months from contractual agreed drawdown date. i.e. 04th January 2022.
(iii) The NCB's are entitled to a fixed coupon rate of interest at 8% per annum.
(iv) The NCB's can be fully or partially repaid before the contractual repayment dates, subject to compliance
with applicable regulations in India
During the year ended 31st March 2025 total repayment of borrowings amounted to '2,489.58 Million (31st
March 2024: '2,490.00 Million). Of this voluntary prepayments amounted to 'Nil (31st March 2024: '2,490.00
Million.)
Pursuant to the Amendment deed dated 20th February 2025, the Lender and the Company have deferred the
repayment of '.1,245.00 Million each due on 24th February 2025 and 23rd May 2025 to 23rd March 2025 and
23rd June 2025 respectively.
The Company offsets deferred tax assets and liabilities if and only if it has a legally enforceable right to set
off current tax assets and current tax liabilities and the deferred tax assets and deferred tax liabilities relate
to income taxes levied by the same tax authority.
34 Earnings per share ("EPS”)
Basic EPS amounts are calculated by dividing the profit/ (loss) for the year attributable to equity holders of the
Company by the weighted average number of equity shares outstanding during the year. Diluted EPS amounts are
calculated by dividing the profit/(loss) attributable to the equity holders of the Company by the weighted average
number of equity shares outstanding during the year plus the weighted average number of equity shares that would
be issued on conversion of all the dilutive potential equity shares into equity shares.
35 Segment information
The Company publishes the standalone financial statements along with the consolidated financial statements.
In accordance with Ind AS 108, Operating segments. the Company has disclosed the segment information in
the consolidated financial statements and is exempt from disclosing segment information in the standalone
financial statements.
Major Customers greater than 10% of total revenue
Revenue from two customers (one customer group) (31st March 2024 : two ) cumulatively accounted for 100% of
the revenue from operations.
37 Employee benefits
a) Defined contribution plans:
The contributions paid/ payable to Employee Provident Fund, Employees State Insurance Scheme and other
funds, are determined under the relevant approved schemes and statutes and are recognised as an expense
in the standalone statement of profit and loss during the year in which the employee renders the related
service. There are no further obligations other than the contributions payable to the appropriate authorities
by the Company.
During the year, the Company has recognised the following amounts in the standalone statement of profit and
loss, which are included in contribution to provident and other funds:
b) Compensated absences:
The leave obligation pertains to the Company liability towards compensated absences. The entire amount of
the provision of '341.17 millions (31st March 2024 : '293.86 millions) for compensated absences is presented
as a current liability, as the Company does not have an unconditional right to defer its settlement beyond 12
months from the reporting date.
c) Defined benefit plans - Gratuity in India
The Company has a defined benefit gratuity plan in accordance with The Payment of Gratuity Act, 1972. The
plan entitles an employee who has rendered at least five years of continuous service to receive 15 days salary
for every completed year of service or part thereof in excess of six months based on the rate of last drawn
salary (basic plus dearness allowance) by the employee concerned. The Company's liability is actuarially
determined (using the Projected Unit Credit method) at the end of each year. Actuarial gains/ (losses) are
recognised under other comprehensive income in the standalone statement of profit and loss.
Based on the actuarial valuation obtained in this respect, the following table sets out the details of the employee
benefit obligation and the plan assets as at the respective reporting dates:
The above sensitivity analysis is based on a change in an assumption while holding all other assumptions
constant. In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated.
When calculating the sensitivity of the defined benefit obligation to significant actuarial assumptions the same
method (present value of the defined benefit obligation calculated with the projected unit credit method at
the end of the reporting period) has been applied as when calculating the defined benefit liability recognised
in the standalone financial statements.
The methods and types of assumptions used in preparing the sensitivity analysis did not change compared
to the prior period.
Sensitivities due to mortality and withdrawals are not material and hence impact of change was not calculated.
The fair value of cash and cash equivalents, trade receivables (including unbilled receivables), trade payables,
other financial assets and liabilities approximate the carrying amount thereof as at 31st March 2025 and 31st
March 2024, largely due to the short-term nature of these instruments.
*The fair value of derivative financial instruments is determined based on observable market inputs including currency spot and
forward rates, and currency volatility.
#Discounted cash flows: The valuation model considers the present value of expected payments, discounted using a risk-adjusted
discount rate. The own non-performance risk was assessed to be insignificant.
(a) Fair value hierarchy
The section explains the judgements and estimates made in determining the fair value of the financial
instruments that are:
a) recognised and measured at fair value.
b) measured at amortised cost and for which fair values are disclosed in the financial statement.
To provide an indication of the reliability of the inputs used in determining fair value, the Company has classified
its financial instruments into three levels as mentioned under Indian Accounting Standards.
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability,
either directly (i.e. as prices) or indirectly (i.e. derived from prices).
Level 3: Inputs for the assets or liabilities that are not based on observable market data (unobservable inputs).
There were no changes in fair value hierarchy during the previous year.
Valuation techniques and significant unobservable inputs
Level 2:
Forward exchange contracts: The fair value is determined using quoted forward exchange rates at the reporting
date and present value calculations based on yield curves in the respective currencies.
39 Financial instruments - risk management
The Company has exposure to the following risks arising from financial instruments: credit risk (refer note (b) below);
liquidity risk (refer note (c) below); market risk (refer note (d) below).
(a) Risk management framework
The Risk Management Committee of the Board of Directors have the overall responsibility for the establishment
and oversight of the Company's risk management framework. The Company's risk management policies are
established to identify and analyse the risks faced by the Company, to set appropriate risk limits and controls
and to monitor risks and adherence to limits. Risk management policies and systems are reviewed regularly
to reflect changes in market conditions and the Company's activities.
The Company's Board of Directors oversees how management monitors compliance with the Company's risk
management policies and procedures, and reviews the adequacy of the risk management framework in relation
to the risks faced by the Company. The Board is assisted in its oversight role by internal audit. Internal audit
undertakes both regular and adhoc reviews of risk management controls and procedures, the results of which
are reported to the Board and appropriate corrective actions are taken as required.
(b) Credit risk
Credit risk is the risk of financial loss to the Company if a customer or a counterparty to any other financial
instrument fails to meet its contractual obligations. Credit risk encompasses both the direct risk of default
and the risk of deterioration of creditworthiness as well as concentration of risks. The Company is exposed to
credit risk from its operating activities (primarily trade receivables) and from its investing activities derivative
financial instruments and security deposits.
Financial assets that are neither past due nor impaired
The Company has an established process to evaluate the creditworthiness of its customers to minimise potential
credit risk. Credit evaluations are performed by the Company before agreements to render services are entered into
with prospective customers. Outstanding customer receivables are regularly monitored. Two customer individually
accounted for more than 10% of the outstanding trade receivable as at 31st March 2025 (31st March 2024 : two)
The Company's credit period generally ranges from 60-90 days. The amounts outstanding in the balance
sheet represent the maximum exposure to credit risk. The concentration risk with respect to trade receivables
is high since these are receivables from two customer and one group. "
The Company establishes an allowance account for impairment that represents its estimate of losses in respect
of trade and other receivables. The allowance account is used to provide for impairment losses. Subsequently
when the Companyis satisfied that no recovery of such losses is possible, the financial asset is considered
irrecoverable and the amount charged to the allowance account is then written off against the carrying amount
of the impaired financial asset.
The Company generate revenue from two of its subsidiaries which contribute more than 10% of total revenue
of the Company, individually and 100% of the Company's revenue, collectively.
Financial instruments, deposits and balances with banks
Credit risk is limited as the Company generally invests in deposits with banks and derivatives with high credit
ratings assigned by international and domestic credit rating agencies. Counterparty credit limits are reviewed
by the Company periodically and the limits are set to minimise the concentration of risks and therefore mitigate
financial loss through counterparty's potential failure to make payments.
(c) Liquidity risk
Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with
its financial liabilities that are settled by delivering cash or another financial asset. The Company's approach
to managing liquidity is to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities
when they are due, under both normal and stressed conditions, without incurring unacceptable losses or risking
damage to the Company's reputation. The Company believes that the working capital is sufficient to meet its
current requirements. Accordingly, no significant liquidity risk is perceived.
(i) Maturities of financial liabilities
The following are the remaining contractual maturities of financial liabilities at the reporting date. The
amounts are gross and undiscounted contractual cash flows, and include contractual interest payments
and exclude the impact of netting agreements.
As of 31st March 2025, the Company had a working capital of '5,859.84 Million (31st March 2024: '4,346.42
Million) including cash and cash equivalents of '899.44 Million (31st March 2024: '209.31 Million) and
receivables of '8,913.18 Million (31st March 2024: '8,343.99 Million).
(d) Market risk
Market risk is the risk that changes in market prices which is mainly foreign exchange rates affect the Company's
income or the value of its holdings of financial instruments. The objective of market risk management is to
manage and control market risk exposures within acceptable parameters, while optimising the return.
i) Currency risk
(a) Foreign currency risk exposure
The exposure to foreign currency risk at the end of the reporting period expressed in ', are as follows:
(b) Impact of hedging activities
The Company's hedging policy only allows for effective hedge relationships to be established. Hedge
effectiveness is determined at the inception of the hedge relationship and through periodic prospective
effectiveness assessments to ensure that an economic relationship exists between the hedged item and
hedging instrument. The Company enters into hedge relationships where the critical terms of the hedging
instrument match exactly with the terms of the hedged item.
As the critical terms of the hedging instruments and their corresponding hedged items are the same, the
Company performs a qualitative assessment of effectiveness and it is expected that the value of the hedging
instruments and the value of the corresponding hedged items will systematically change in opposite direction
in response to movements in the underlying exchange rates.
The Company monitors the aforesaid critical terms on a regular basis to assess if the hedging relationship
remains highly effective. Hedge ineffectiveness is recognised on a cash flow hedge in the statement of profit
and loss. Ineffectiveness represents remaining portion of gain or loss on the hedging instrument that cannot
be offset with the change in the fair value of the hedged item.
The table below analyses the derivative financial instruments into relevant maturity accompanyings based on
the remaining maturity period as at the respective reporting dates:
ii) Interest rate risk
Interest rate on the Company's borrowings are fixed, hence there is no interest rate risk.
40 Capital management
For the purpose of the Company's capital management, capital includes issued equity capital and all other equity
reserves attributable to the equity holders of the Company. The primary objective of the Company's capital
management is to maximise the shareholder value.
The Company's policy is to maintain a strong capital base so as to maintain investor, creditor and market confidence
and to sustain future development of the business. The Company's capital structure includes debt and is influenced
by the changes in regulatory framework, government policies, available options of financing and the impact of the
same on the liquidity position.
The Company monitors capital using a ratio of 'adjusted net debt' to 'adjusted equity'. For this purpose, adjusted net
debt is defined as total liabilities, including interest-bearing loans and borrowings less cash and cash equivalents
and other bank balances. Adjusted equity comprises all components of equity except hedge reserve.
43 Capital and other commitments
Capital commitments
Estimated amount of contracts remaining to be executed on capital account and not provided (net of advances)
amount to '39.21 Million (31st March 2024 : '110.23 Million).
44 Transfer pricing
The Finance Act, 2001 has introduced, with effect from assessment year 2002-03 (effective 1st April 2001), detailed
transfer pricing regulations for computing the taxable income and expenditure from 'international transactions'
between 'associated enterprises' on 'arm's length' basis. These regulations, inter alia, also require the maintenance
of prescribed documents and information including furnishing a report from an Accountant within the due date
of filing return of income. The Company has undertaken necessary steps to comply with the Transfer Pricing
regulations and the prescribed certificate from the accountant will be obtained for the year ended 31st March 2025
within the due date. The management is of the opinion that the international transactions are at arm's length, and
hence the aforesaid legislation will not have any impact on the financial statements, particularly on the amount of
tax expense and that of the provision for taxation.Share based payments arrangements
45 Share based payments arrangements
Share based payments arrangements plan
In June 2022, the immediate holding company issued share appreciation rights (SARs) to certain identified employees
and non-executive directors of the Group. Each SAR granted entitles the employees/non-executive directors to
a cash payout, computed as the difference between the distribution threshold of the SAR ('strike price') and the
fair value of the SAR on the date the awards are fully vested. The SAR's issued will vest in five annual installments,
subject to continued employment with the Group up to the vesting date and achievement of certain defined financial
performance targets. However, such awards would only be conditionally vested as on the date when the service
and performance conditions are met. 100% of the conditionally vested awards would unconditionally vest upon a
change in control event, defined to be a date when the immediate holding company holds no more than 24% of the
issued and outstanding equity share capital of the Company.
For certain employees, such time based vesting is 75% of the awards issued to them. The balance 25% of the
awards will vest upon a change in control event, defined to be a date when the immediate holding company holds
no more than 24% of the issued and outstanding equity share capital of the Company.
These awards were classified as liability settled cash awards till 25th June 2024, as the Company had an obligation
to make payments in cash upon vesting of the awards as explained above. Pursuant to an amendment agreement
entered into with the identified employees and non-executive directors on 25th June 2024, the obligation to settle
these awards has been restricted to the immediate holding company only. Accordingly, with effect from 25th
June 2024, the Company does not have the obligation to settle the awards in cash. The Company considers the
amendment to be a modification of the awards. Additionally, based on the revised agreements, the Company
considers the awards to be equity settled in nature.
Pursuant to such modification, the incremental fair value of all awards granted and outstanding as on the modification
date amounted to '273 Million. Such incremental fair value of the awards is being accounted for over the vesting
term of the awards on a graded basis. The incremental fair value was computed as a difference between the grant
date fair value of the awards on the modification date computed in accordance with the Black Scholes option
pricing model and the fair value of the awards just before modification based on fair value of the immediate holding
company considering it was cash settled awards.
Expected volatility has been based on an evaluation of the historical volatility of the share price of the comparable
listed companies, particularly over the historical period commensurate with the expected term. The expected
term of the awards has been based on historical experience, general award holder behaviour and management's
expectation of the change in control event as defined above.
During the year ended 31st March 2025, Nil awards were issued to key management personnel (31st March 2024
: Nil)
Pursuant to increase in fair value of the awards measured based on a cash settled liability together with the increase
in fair value of awards pursuant to modification as explained above, total employee compensation cost pertaining
to share based payment awards, recognized during the year ended 31st March 2025 amounted to '646.70 Million
(31st March 2024 : '49.76 Million)
47 Additional Regulatory Information required under Schedule III
(i) Utilisation of borrowed funds and share premium
I The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including
foreign entities (Intermediaries) with the understanding that the Intermediary shall
(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or
on behalf of the Company (Ultimate Beneficiaries); or
(b) provide any guarantee, security or the like to or on behalf of the ultimate beneficiaries
II The Company has not received funds from any person(s) or entit(ies), including foreign entities ("Funding
Parties”), with the understanding, whether recorded in writing or otherwise, that the Company shall :
(a) directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or
on behalf of the Funding Parties ("Ultimate Beneficiaries”) or
(b) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.
48 Corporate Social Responsibility ("CSR")
Pursuant to the provisions of section 135(5) of the Companies Act, 2013 (the Act), the Company has formed its
Corporate Social Responsibility (CSR) Committee. The CSR committee of the Company provides an oversight of
CSR policy execution to ensure that CSR objectives of the Company are met
49 Code on Social Security
The Code on Social Security 2020 ('Code'), which received the Presidential Assent on 28th September 2020,
subsumes nine regulations relating to social security, retirement, and employee benefits. The Code will have an
impact on the contributions towards gratuity and provident fund made by the Holding Company. The Ministry
of Labour and Employment ('Ministry') has released draft rules for the Code on 13th November 2020 and has
invited suggestions from stake holders. The suggestions received are under consideration by the Ministry. The
effective date of the Code has not yet been notified and the related rules to ascertain the financial impact are yet
to be finalized and notified. The Company will assess the impact once the subject rules are notified and will give
appropriate impact in its financial information in the period in which, the Code becomes effective and the related
rules to determine the financial impact are published.
As per our report of even date
for B S R & Co. LLP for and on behalf of the Board of Directors of
Chartered Accountants Sagility India Limited
Firm registration number: (formerly known as Sagility India Private Limited and prior
101248W/W-100022 to that Berkmeer India Private Limited)
Hemanth Bhasin Anil Kumar Chanana Ramesh Gopalan
Partner Director Managing Director & Group Chief Executive Officer
Membership No: 235040 DIN-00466197 DIN-00636524
Sarvabhouman Doraiswamy Srinivasan Satishkumar Sakharayapattana Seetharamaiah
Group Chief Financial Officer Company Secretary & Compliance Officer
ACS16008
Place: Bengaluru Place: Bengaluru
Date: 14th May 2025 Date: 14th May 2025
|